SYNAPS Dx Announces Investment by Semler Scientific: Advances Positioning, Accelerates Commercialization of DISCERN Test for Diagnosing Early Alzheimer’s Disease
ROCKVILLE, Md.–(BUSINESS WIRE)–The announcement of a recent investment from Semler Scientific (SMLR) in SYNAPS Dx…